We seek to understand molecular regulatory mechanisms controlling breast tissue development andtransformation. SWI/SNF chromatin remodeling enzymes control the accessibility of genomic chromatin andare vitally important in the initiation of multiple differentiation programmes through regulation of cell cycleprogresson and gene expression. These enzymes interact with tumor suppressors, and individual subunitsare tumor suppressors themselves. The Runx2 transcriptional regulator plays an essential role indsteogenesis and is expressed at greatly elevated levels in breast and other cancer cells. The oncogenicpotential of Runx family members is an emerging theme in the characterization of numerous tumor types.Our preliminary studies indicate that both SWI/SNF enzymes and the Runx2 factor can modulate geneexpression, nuclear and cellular morphology, and tissue development in breast cells. Since developmentand malignant transformation take place in a three dimensional context, we are utilizing model systems ofnormal and transformed breast cells that recapitulate the microenvironment of a tissue and that permit thedynamic and reciprocal crosstalk between the extracellular matrix and nuclear gene expression. The fidelityof these systems to in vivo breast biology is essential to our efforts to understand regulatory mechanismscontrolling normal and tumorigenic processes in breast cells.We will define the requirements for SWI/SNF chromatin remodeling enzymes (Aim 1) and Runx2 (Aim 2) innormal and transformed tissue formation using breast epithelial cells grown in a three dimensional,reconstituted basement membrane culture by exploring how these factors affect the interplay betweensignaling from the tissue microenvironment and nuclear gene expression. Additionally, we will address howthese factors cooperate (Aim 3) in highly transformed breast cell lines to promote metastatic phenotypes.LAY SUMMARY: The relationship between molecular factors controlling cell growth and development andthe three dimensional environment in which the cells of a tissue exist has only recently begun to beinvestigated. We seek to understand how molecular regulatory factors and the tissue microenvirnmentcontribute to normal breast development as well as to the development of breast cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
2P01CA082834-06
Application #
7055025
Study Section
Special Emphasis Panel (ZCA1-RPRB-M (O1))
Project Start
2006-02-01
Project End
2011-01-31
Budget Start
2006-02-01
Budget End
2007-01-31
Support Year
6
Fiscal Year
2006
Total Cost
$151,215
Indirect Cost
Name
University of Massachusetts Medical School Worcester
Department
Type
DUNS #
603847393
City
Worcester
State
MA
Country
United States
Zip Code
01655
Araya, H├ęctor F; Sepulveda, Hugo; Lizama, Carlos O et al. (2018) Expression of the ectodomain-releasing protease ADAM17 is directly regulated by the osteosarcoma and bone-related transcription factor RUNX2. J Cell Biochem 119:8204-8219
Carver, Gary E; Locknar, Sarah A; Weaver, Donald L et al. (2018) Real-time detection of breast cancer at the cellular level. J Cell Physiol :
Tracy, Kirsten M; Tye, Coralee E; Ghule, Prachi N et al. (2018) Mitotically-Associated lncRNA (MANCR) Affects Genomic Stability and Cell Division in Aggressive Breast Cancer. Mol Cancer Res 16:587-598
Zaidi, Sayyed K; Fritz, Andrew J; Tracy, Kirsten M et al. (2018) Nuclear organization mediates cancer-compromised genetic and epigenetic control. Adv Biol Regul 69:1-10
Hong, Deli; Fritz, Andrew J; Finstad, Kristiaan H et al. (2018) Suppression of Breast Cancer Stem Cells and Tumor Growth by the RUNX1 Transcription Factor. Mol Cancer Res 16:1952-1964
Zaidi, Sayyed K; Nickerson, Jeffrey A; Imbalzano, Anthony N et al. (2018) Mitotic Gene Bookmarking: An Epigenetic Program to Maintain Normal and Cancer Phenotypes. Mol Cancer Res 16:1617-1624
Hong, Deli; Fritz, Andrew J; Zaidi, Sayyed K et al. (2018) Epithelial-to-mesenchymal transition and cancer stem cells contribute to breast cancer heterogeneity. J Cell Physiol 233:9136-9144
Farina, Nicholas H; Zingiryan, Areg; Vrolijk, Michael A et al. (2018) Nanoparticle-based targeted cancer strategies for non-invasive prostate cancer intervention. J Cell Physiol 233:6408-6417
Tracy, Kirsten M; Tye, Coralee E; Page, Natalie A et al. (2018) Selective expression of long non-coding RNAs in a breast cancer cell progression model. J Cell Physiol 233:1291-1299
Hong, Deli; Fritz, Andrew J; Gordon, Jonathan A et al. (2018) RUNX1-dependent mechanisms in biological control and dysregulation in cancer. J Cell Physiol :

Showing the most recent 10 out of 213 publications